Cargando…

Knowledge barriers in a national symptomatic-COVID-19 testing programme

Symptomatic testing programmes are crucial to the COVID-19 pandemic response. We sought to examine United Kingdom (UK) testing rates amongst individuals with test-qualifying symptoms, and factors associated with not testing. We analysed a cohort of untested symptomatic app users (N = 1,237), nested...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, Mark S., May, Anna, Varsavsky, Thomas, Sudre, Carole H., Murray, Benjamin, Kläser, Kerstin, Antonelli, Michela, Canas, Liane S., Molteni, Erika, Modat, Marc, Cardoso, M. Jorge, Drew, David A., Nguyen, Long H., Rader, Benjamin, Hu, Christina, Capdevila, Joan, Hammers, Alexander, Chan, Andrew T., Wolf, Jonathan, Brownstein, John S., Spector, Tim D., Ourselin, Sebastien, Steves, Claire J., Astley, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022193/
https://www.ncbi.nlm.nih.gov/pubmed/36962066
http://dx.doi.org/10.1371/journal.pgph.0000028
_version_ 1784908676052549632
author Graham, Mark S.
May, Anna
Varsavsky, Thomas
Sudre, Carole H.
Murray, Benjamin
Kläser, Kerstin
Antonelli, Michela
Canas, Liane S.
Molteni, Erika
Modat, Marc
Cardoso, M. Jorge
Drew, David A.
Nguyen, Long H.
Rader, Benjamin
Hu, Christina
Capdevila, Joan
Hammers, Alexander
Chan, Andrew T.
Wolf, Jonathan
Brownstein, John S.
Spector, Tim D.
Ourselin, Sebastien
Steves, Claire J.
Astley, Christina M.
author_facet Graham, Mark S.
May, Anna
Varsavsky, Thomas
Sudre, Carole H.
Murray, Benjamin
Kläser, Kerstin
Antonelli, Michela
Canas, Liane S.
Molteni, Erika
Modat, Marc
Cardoso, M. Jorge
Drew, David A.
Nguyen, Long H.
Rader, Benjamin
Hu, Christina
Capdevila, Joan
Hammers, Alexander
Chan, Andrew T.
Wolf, Jonathan
Brownstein, John S.
Spector, Tim D.
Ourselin, Sebastien
Steves, Claire J.
Astley, Christina M.
author_sort Graham, Mark S.
collection PubMed
description Symptomatic testing programmes are crucial to the COVID-19 pandemic response. We sought to examine United Kingdom (UK) testing rates amongst individuals with test-qualifying symptoms, and factors associated with not testing. We analysed a cohort of untested symptomatic app users (N = 1,237), nested in the Zoe COVID Symptom Study (Zoe, N = 4,394,948); and symptomatic respondents who wanted, but did not have a test (N = 1,956), drawn from a University of Maryland survey administered to Facebook users (The Global COVID-19 Trends and Impact Survey [CTIS], N = 775,746). The proportion tested among individuals with incident test-qualifying symptoms rose from ~20% to ~75% from April to December 2020 in Zoe. Testing was lower with one vs more symptoms (72.9% vs 84.6% p<0.001), or short vs long symptom duration (69.9% vs 85.4% p<0.001). 40.4% of survey respondents did not identify all three test-qualifying symptoms. Symptom identification decreased for every decade older (OR = 0.908 [95% CI 0.883–0.933]). Amongst symptomatic UMD-CTIS respondents who wanted but did not have a test, not knowing where to go was the most cited factor (32.4%); this increased for each decade older (OR = 1.207 [1.129–1.292]) and for every 4-years fewer in education (OR = 0.685 [0.599–0.783]). Despite current UK messaging on COVID-19 testing, there is a knowledge gap about when and where to test, and this may be contributing to the ~25% testing gap. Risk factors, including older age and less education, highlight potential opportunities to tailor public health messages. The testing gap may be ever larger in countries that do not have extensive, free testing, as the UK does.
format Online
Article
Text
id pubmed-10022193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100221932023-03-17 Knowledge barriers in a national symptomatic-COVID-19 testing programme Graham, Mark S. May, Anna Varsavsky, Thomas Sudre, Carole H. Murray, Benjamin Kläser, Kerstin Antonelli, Michela Canas, Liane S. Molteni, Erika Modat, Marc Cardoso, M. Jorge Drew, David A. Nguyen, Long H. Rader, Benjamin Hu, Christina Capdevila, Joan Hammers, Alexander Chan, Andrew T. Wolf, Jonathan Brownstein, John S. Spector, Tim D. Ourselin, Sebastien Steves, Claire J. Astley, Christina M. PLOS Glob Public Health Research Article Symptomatic testing programmes are crucial to the COVID-19 pandemic response. We sought to examine United Kingdom (UK) testing rates amongst individuals with test-qualifying symptoms, and factors associated with not testing. We analysed a cohort of untested symptomatic app users (N = 1,237), nested in the Zoe COVID Symptom Study (Zoe, N = 4,394,948); and symptomatic respondents who wanted, but did not have a test (N = 1,956), drawn from a University of Maryland survey administered to Facebook users (The Global COVID-19 Trends and Impact Survey [CTIS], N = 775,746). The proportion tested among individuals with incident test-qualifying symptoms rose from ~20% to ~75% from April to December 2020 in Zoe. Testing was lower with one vs more symptoms (72.9% vs 84.6% p<0.001), or short vs long symptom duration (69.9% vs 85.4% p<0.001). 40.4% of survey respondents did not identify all three test-qualifying symptoms. Symptom identification decreased for every decade older (OR = 0.908 [95% CI 0.883–0.933]). Amongst symptomatic UMD-CTIS respondents who wanted but did not have a test, not knowing where to go was the most cited factor (32.4%); this increased for each decade older (OR = 1.207 [1.129–1.292]) and for every 4-years fewer in education (OR = 0.685 [0.599–0.783]). Despite current UK messaging on COVID-19 testing, there is a knowledge gap about when and where to test, and this may be contributing to the ~25% testing gap. Risk factors, including older age and less education, highlight potential opportunities to tailor public health messages. The testing gap may be ever larger in countries that do not have extensive, free testing, as the UK does. Public Library of Science 2022-01-19 /pmc/articles/PMC10022193/ /pubmed/36962066 http://dx.doi.org/10.1371/journal.pgph.0000028 Text en © 2022 Graham et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Graham, Mark S.
May, Anna
Varsavsky, Thomas
Sudre, Carole H.
Murray, Benjamin
Kläser, Kerstin
Antonelli, Michela
Canas, Liane S.
Molteni, Erika
Modat, Marc
Cardoso, M. Jorge
Drew, David A.
Nguyen, Long H.
Rader, Benjamin
Hu, Christina
Capdevila, Joan
Hammers, Alexander
Chan, Andrew T.
Wolf, Jonathan
Brownstein, John S.
Spector, Tim D.
Ourselin, Sebastien
Steves, Claire J.
Astley, Christina M.
Knowledge barriers in a national symptomatic-COVID-19 testing programme
title Knowledge barriers in a national symptomatic-COVID-19 testing programme
title_full Knowledge barriers in a national symptomatic-COVID-19 testing programme
title_fullStr Knowledge barriers in a national symptomatic-COVID-19 testing programme
title_full_unstemmed Knowledge barriers in a national symptomatic-COVID-19 testing programme
title_short Knowledge barriers in a national symptomatic-COVID-19 testing programme
title_sort knowledge barriers in a national symptomatic-covid-19 testing programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022193/
https://www.ncbi.nlm.nih.gov/pubmed/36962066
http://dx.doi.org/10.1371/journal.pgph.0000028
work_keys_str_mv AT grahammarks knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT mayanna knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT varsavskythomas knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT sudrecaroleh knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT murraybenjamin knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT klaserkerstin knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT antonellimichela knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT canaslianes knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT moltenierika knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT modatmarc knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT cardosomjorge knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT drewdavida knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT nguyenlongh knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT raderbenjamin knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT huchristina knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT capdevilajoan knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT hammersalexander knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT chanandrewt knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT wolfjonathan knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT brownsteinjohns knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT spectortimd knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT ourselinsebastien knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT stevesclairej knowledgebarriersinanationalsymptomaticcovid19testingprogramme
AT astleychristinam knowledgebarriersinanationalsymptomaticcovid19testingprogramme